Inventor · Manvel, TX, US

Ananth Annapragada

23Patents
5h-index
30Co-inventors
69Inventor score

Filing activity: Jul 25, 1988 → Feb 1, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7713517B2 Compositions and methods for enhancing contrast in imaging Human Necessities 10 Active
US7785568B2 Compositions and methods for enhancing contrast in imaging Human Necessities 9 Active
US8357351B2 Nano-scale contrast agents and methods of use Human Necessities 6 Active
US8642013B2 Nano-scale contrast agents and methods of use Human Necessities 5 Active
US8911708B2 Nano-scale contrast agents and methods of use Human Necessities 5 Active
US8679531B2 Vesicle compositions Human Necessities 5 Active
US4952547A Catalyst for converting methane to higher hydrocarbons, including aromatic compounds Emerging Cross-Sectional Technologies 2 Expired
US9744251B2 MRI imaging of amyloid plaque using liposomes Human Necessities 1 Active
US9801957B2 Lipid-based nanoparticles Human Necessities 0 Active
US11312685B2 Targeting nanoparticles Human Necessities 0 Active
US11141495B2 MRI imaging of amyloid plaque using liposomes Human Necessities 0 Active
US12298318B2 Targeting ligands for tau pathology Physics 0 Active
US10124078B2 Lipid-based nanoparticles Chemistry; Metallurgy 0 Active
US12097269B2 Dual mode gadolinium nanoparticle contrast agents Human Necessities 0 Active
US9278068B2 Vesicle compositions Human Necessities 0 Active
USRE45195E1 Compositions and methods for enhancing contrast in imaging General 0 Active
US11779664B2 Targeted contrast agents for MRI of alpha-synuclein deposition Chemistry; Metallurgy 0 Active
US11614451B2 Targeting ligands for tau pathology Physics 0 Active
US11241510B2 Hydrophilic fluorinated molecules for liposomal 19F MRI probes with unique MR signatures Chemistry; Metallurgy 0 Active
US11116854B2 Targeted contrast agents for MRI of amyloid deposition Human Necessities 0 Active
US10130326B2 Methods and compositions for objectively characterizing medical images Physics 0 Active
US10537649B2 MRI imaging of amyloid plaque using liposomes Human Necessities 0 Active
US11052162B2 Liposomal gadolinium (GD) contrast agent “NMRX” for T1-MRI Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.